Browsing by Author Abdel-Aziz, Amal Kamal

Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
Jul-2018Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic MachineriesEl-Agamy, Sara Emad; Abdel-Aziz, Amal Kamal; Sara Abdel Moneim Wahdan ; Esmat, Ahmed; Azab, Samar S
15-Feb-2022Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemiaDokla, Eman ; Abdel-Aziz, Amal Kamal; Milik, Sandra N.; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid 
1-Dec-2021Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancerDokla, Eman ; Abdel-Aziz, Amal Kamal; Milik, Sandra N.; Mahmoud, Amr H.; Saadeldin, Mona Kamal; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid 
15-Dec-2020Novel molecular mechanisms underlying the ameliorative effect of N-acetyl-L-cysteine against ϒ-radiation-induced premature ovarian failure in ratsMantawy, Eman M.; Said, Riham S.; Kassem, Dina ; Abdel-Aziz, Amal Kamal; Badr, Amira Mohamed
15-Jul-2018Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitorsMilik, Sandra N; Abdel-Aziz, Amal Kamal; Serya, Rabah ; Minucci, Saverio; Lasheen, Deena S. ; Khaled A M Abouzid